Automated Reinforcement Management Systems, Phase II

Description

The Automated Reinforcement Management Systems Phase II (ARMS II) study is a phase II trial is a randomized controlled, non-medicated assisted trial to determine the effectiveness of Contingency Management (CM) treatment for reducing alcohol drinking among adults who want to quit or reduce their alcohol consumption.

Conditions

Alcohol Use Disorder

Talk to us

Study Overview

On this page

Study Details

Study overview

The Automated Reinforcement Management Systems Phase II (ARMS II) study is a phase II trial is a randomized controlled, non-medicated assisted trial to determine the effectiveness of Contingency Management (CM) treatment for reducing alcohol drinking among adults who want to quit or reduce their alcohol consumption.

Automated Reinforcement Management Systems, Phase II

Automated Reinforcement Management Systems, Phase II

Condition
Alcohol Use Disorder
Intervention / Treatment

-

Contacts and Locations

Spokane

Washington State University, Spokane, Washington, United States, 99202

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Age 18-70 years
  • * Have consumed 3 or more drinks in once occasion 4 or more times in the previous 30 days 3
  • * Have the ability to read and speak English
  • * Have the ability to provide written informed consent
  • * Have a breath alcohol value of 0.00 during informed consent
  • * Owns a smartphone with an active service provider that is compatible with the study application.
  • * Severe alcohol use disorder that our medical staff deems too risky for safe participation;
  • * Significant risk of dangerous alcohol withdrawal, defined as history of seizure due to alcohol withdrawal in the last 12 months and/or expression of concern by the participant about dangerous withdrawal
  • * Anyone aged 71 or older.
  • * Anyone with a suicide attempt in the last 2 years.
  • * Individuals who express concern regarding dangerous withdrawal or who exhibit dangerous withdrawal symptoms.
  • * Individuals who do not test BrAC = 0.00 on the breathalyzer during the baseline visit.
  • * Any other condition that investigators determine a medical or psychiatric condition that would compromise safe study participation.

Ages Eligible for Study

18 Years to 70 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

Yes

Collaborators and Investigators

Washington State University,

Sterling M McPherson, PhD, PRINCIPAL_INVESTIGATOR, Washington State University

Study Record Dates

2025-09-01